Vaughan v. Federal National Mortgage Association - Contract Dispute

This filing concerns the case Vaughan et al v. Federal National Mortgage Association et al, Case Number 4:25-cv-00479-ASK. Recent filings include oppositions to motions to dismiss the second amended complaint and a motion for an extension of time to file a response.

Amit Khanna Case - Notice of Administrative Motion Error

The U.S. District Court for the Northern District of California has received a notice regarding case 3:25-cv-06977-VC. Amit Khanna filed a notice stating that a third administrative motion for a 48-hour extension was filed in error and requested it be stricken.

Means v. Lyft, Inc. - Pro Hac Vice Motion Granted

In the case of Means v. Lyft, Inc., the court has granted a motion for Pro Hac Vice appearance. This order allows an out-of-state attorney to practice in a specific case before the court. The case is part of a Multi-District Litigation.

FDA Amends Animal Drug Approval and Withdrawal Rules

The Food and Drug Administration (FDA) has amended regulations concerning the approval and withdrawal of new animal drug applications. These changes are effective February 6, 2026, and impact the procedures for drug sponsors and the handling of drug approvals.

FDA Allows Spirulina Extract as Color Additive in Human Foods

The Food and Drug Administration (FDA) has issued a final rule allowing spirulina extract to be used as a color additive in human foods. This rule amends the list of color additives exempt from certification. The comment period for this rule closes on March 9, 2026.

FDA Amends Food Coloring Regulations for Beetroot Red

The Food and Drug Administration (FDA) has amended regulations concerning the use of beetroot red as a food coloring additive. This rule finalizes changes to the listing of color additives exempt from certification, specifically impacting beetroot red.

FDA Revokes Mutual Recognition of EU Pharma and Device Reports

The Food and Drug Administration (FDA) is revoking regulations that allowed for the mutual recognition of pharmaceutical Good Manufacturing Practice (GMP) reports and medical device quality system audit reports with the European Community. This action will impact the oversight and inspection processes for products traded between the US and the EU.

FDA Revokes Methods of Analysis Regulation

The Food and Drug Administration (FDA) is revoking its regulation concerning methods of analysis. This rule, published in the Federal Register, will be effective March 23, 2026. The revocation impacts how certain analytical methods are regulated.

Proposed Amendments to Form N-PORT Reporting for Investment Companies

The Securities and Exchange Commission has proposed amendments to Form N-PORT reporting requirements for investment companies and ETFs. This proposal includes changes to the data elements and reporting format, with a comment period ending on April 24, 2026.

SEC Extends Form N-PORT Compliance Dates

The Securities and Exchange Commission (SEC) has extended the compliance dates for Form N-PORT reporting for investment companies. This rule change, published on February 23, 2026, provides additional time for affected entities to comply with the reporting requirements.